FGFR3 GENE MUTATION
Clinical trials for FGFR3 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE MUTATION trials appear
Sign up with your email to follow new studies for FGFR3 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could fight bladder cancer without surgery
Disease control Recruiting nowThis Phase 2 trial tests an oral drug called TYRA-300 in 90 adults with a low-grade, intermediate-risk bladder cancer that has not invaded muscle. The cancer must have a specific genetic change (FGFR3 alteration). Participants take a daily tablet for up to 2 years. The main goal …
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New pill targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage trial tests a new daily pill called TYRA-430 in 100 adults with advanced liver cancer or other solid tumors that have specific genetic changes. The main goals are to find the safest dose and check for side effects. Researchers will also look for signs that the dr…
Matched conditions: FGFR3 GENE MUTATION
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC